Tailored Nanoparticle Codelivery of antimiR-21 and antimiR-10b Augments Glioblastoma Cell Kill by Temozolomide: Toward a “Personalized” Anti-microRNA Therapy
Year: 2016
Type: article
Source: Molecular Pharmaceutics
Institutions: Stanford Medicine, Stanford University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: Ben and Catherine Ivy Foundation
OpenAlex ID: W2498596498
